Remove 2010 Remove Biotechnology Remove Succession Remove Technology
article thumbnail

How to Compete Like the World’s Most Innovative Leaders

Skip Prichard

Whether you have invented an amazing new technology or product, you could still fail. It’s a fascinating study, one that echoes my constant inquiry of the difference between success and failure. You are teaching what separates successful innovators from those who struggle. Innovation Capital. Lessons from Tesla versus Edison.

article thumbnail

A Quiet Revolution in Clean-Energy Finance

Harvard Business Review

Between 2006 and 2008, more than $1 billion venture-capital dollars were channeled into startups focused on solar, wind and biofuel technologies. In the last year, however, early-stage investments in clean energy production technologies have fallen substantially (see the table at the end of this piece for more detail).

Energy 10
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Should Big Companies Give Up on Innovation?

Harvard Business Review

Start-up companies tend to cluster in industries favored by venture capitalists (like biotechnology or information technology) or ones where there are relatively low barriers to entry (like restaurants). In 2010, Embrace entered into a partnership with General Electric to help scale the technology around the globe.

article thumbnail

Searching for Health Care's Entrepreneurial Spirit

Harvard Business Review

And biotechnology and medical devices are among the leading areas for venture capital funding. Very few things in the economy are the same today as they were a half century ago, and most of those are still the same are not considered successes. Fortunes have been made from implants, surgical instruments, and artificial products.